Hemodynamic Stability Discrimination via Pressure Impedance Phase
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Implantable medical devices (IMDs) face challenges in accurately distinguishing between hemodynamically stable and unstable cardiac rhythms, leading to unnecessary high-power therapies during ventricular tachycardia and fibrillation, which can be painful and uncomfortable for patients.
Innovation Solution
The integration of a microprocessor with both pressure and impedance sensors in IMDs to determine hemodynamic stability by analyzing the phase relationship between ventricular pressure and impedance data, allowing for the selective delivery of therapies based on the stability of the cardiac rhythm.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If high-power therapy is delivered immediately upon detecting ventricular tachycardia or fibrillation, then the arrhythmia is treated aggressively and life-saving intervention is provided, but unnecessary shocks are delivered to hemodynamically stable patients causing pain and discomfort
Solution Approach 1:
The system performs preliminary assessment of hemodynamic stability using impedance cardiography parameters (VSW, VCI, VCO) immediately upon arrhythmia detection, before delivering therapy. This preliminary evaluation determines whether the patient is a candidate for shock by assessing whether the arrhythmia is causing hemodynamic instability, thereby avoiding unnecessary shocks to stable patients while ensuring timely intervention for unstable ones
Solution Approach 2:
The system continuously monitors impedance cardiography parameters during the arrhythmia and uses this feedback to determine hemodynamic stability. The VSW, VCI, and VCO values are analyzed in real-time to assess whether the arrhythmia is hemodynamically stable or unstable, providing feedback that guides the therapy delivery decision and enables adaptive response to changing patient conditions
2Loss of time
If therapy is delivered quickly after arrhythmia detection, then treatment time is minimized and patient survival is improved, but the device cannot distinguish between stable and unstable rhythms leading to excessive therapy delivery
Solution Approach 1:
The impedance cardiography measurement system is activated immediately upon arrhythmia detection to perform preliminary assessment of hemodynamic stability. The system calculates VSW, VCI, and VCO parameters quickly to determine whether therapy is needed, enabling both rapid response and accurate discrimination without delaying treatment
Solution Approach 2:
The system uses changes in impedance cardiography parameters (VSW, VCI, VCO) to discriminate between stable and unstable arrhythmias. By monitoring these physiological parameters, the device can accurately assess hemodynamic stability and make informed therapy decisions, improving measurement precision while maintaining quick response time
3Device complexity
If the device monitors only heart rate, then the device complexity is low and operation is simple, but the device cannot accurately distinguish between stable and unstable arrhythmias
Solution Approach 1:
The impedance cardiography system serves multiple functions: it measures hemodynamic stability, discriminates between stable and unstable arrhythmias, and guides therapy delivery decisions. By integrating this multi-functional monitoring capability into the device, the system improves arrhythmia classification accuracy without proportionally increasing complexity
Solution Approach 2:
Impedance cardiography acts as an intermediary measurement system between the ECG-based arrhythmia detection and the therapy delivery decision. It provides additional physiological information (VSW, VCI, VCO) that mediates the decision-making process, enabling accurate discrimination between stable and unstable rhythms while maintaining manageable device complexity
Data Source
AI summary
An implantable cardioverter defibrillator evaluates the hemodynamic stability of an arrhythmia to determine whether or not to defibrillate. The device obtains cardiac pressure and cardiac impedance data and evaluates a phase relationship between these parameters. Hemodynamically stable rhythms will result in an out of phase relationship.